Cristos Ifantides, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    EyeCool Therapeutics
    Date added:
    05/20/2026
    Date updated:
    05/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Individual stocks and stock options
    Ineligible company:
    EyeCool Therapeutics
    Date added:
    05/20/2026
    Date updated:
    05/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Abbvie
    Date added:
    05/20/2026
    Date updated:
    05/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Ace Vision Group
    Date added:
    05/20/2026
    Date updated:
    05/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Ace Vision Group
    Date added:
    05/20/2026
    Date updated:
    05/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Individual stocks and stock options
    Ineligible company:
    Ace Vision Group
    Date added:
    05/20/2026
    Date updated:
    05/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    Bausch and Lomb
    Date added:
    05/20/2026
    Date updated:
    05/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Individual stocks and stock options
    Ineligible company:
    Bausch and Lomb
    Date added:
    05/20/2026
    Date updated:
    05/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Alcon
    Date added:
    05/20/2026
    Date updated:
    05/20/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    Alcon
    Date added:
    05/20/2026
    Date updated:
    05/20/2026

Pages

Return to Masters in Ophthalmology 2026